This inventor holds 1 USPTO granted patent. Top assignees: Charité – Universitätsmedizin Berlin, Children's Medical Center Corporation, Dana-Farber-Cancer Institute Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2024
Title: Inventor Profile: Mattia Sponchioni
Introduction
Mattia Sponchioni is an innovative inventor based in Milan, Italy, known for his significant contribution to the field of medical therapeutics. With a focus on developing advanced compositions and methods for targeting cells, his work addresses critical challenges in disease treatment, particularly in the realms of neurology and oncology.
Latest Patents
Mattia holds one patent titled "Compositions and Methods for Targeting Cells." This invention provides novel compositions and methodologies aimed at delivering therapeutic and diagnostic agents directly to cells, thus enhancing treatment efficacy for diseases including neuroinflammatory conditions and cancer. His approach involves the use of nanoparticles and polymers that are functionalized with various therapeutic agents, capture molecules, and reporter molecules.
Career Highlights
Throughout his career, Mattia has gained valuable experience working with prestigious institutions. He has been associated with the Children's Medical Center Corporation, where he contributed to pediatric medical innovations. Additionally, he has worked at Politecnico di Milano, a leading technical university, where he engaged in significant research and development projects that furthered his expertise in the field.
Collaborations
Mattia has collaborated with various esteemed professionals during his career, including notable coworkers such as Marco Peviani and Alessandra Biffi. Their combined efforts have fostered advancements in pharmaceutical development and cell-targeting technologies.
Conclusion
Mattia Sponchioni stands out as a visionary in the field of therapeutic innovations. His dedication to creating effective methods for cell-targeting demonstrates a commitment to improving health outcomes. Through his inventive spirit and collaborative efforts, Mattia continues to contribute to the ongoing advancement of medical science, positioning himself as a key figure in the fight against complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile